[Structural modification and bioactivity of cyclovirobuxine D].
To search for new compounds for the treatment of cardiovascular diseases by structural modification of cyclovirobuxine D. According to rational drug design principle, a series of cyclovirobuxine D analogues were prepared, and their bioactivities were tested. Ten new compounds were syntheized and confirmed by spectra. Endurance lacking oxygen activity and antiarrhythmia effects of some analogues of cyclovirobuxine D were tested. Some compounds showed better activity than cyclovirobuxine D.